Skip to main content
SpringerLink
Log in

Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report)

  • Original Articles
  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

In order to examine the efficacy of adjuvant chemotherapy employing Mitomycin C (MMC) and carmofur (HCFU) for patients with noncuratively resected colorectal carcinoma, a cooperative study was performed by 54 institutions in the Kyushu and Chugoku areas in Japan. The prospective randomized controlled study consisted of two groups, one receiving only MMC and the other receiving MMC as well as HCFU. Out of an original total of 200, 170 cases were evaluable. Concerning the 30-month survival rate, a better result was observed in the MMC+HCFU group than in the MMC only group (Z-test: p<0.05). Significantly better survival rates were obtained in those cases with disseminating peritoneal metastasis, hepatic metastasis and Stage V cancer in the MMC+HCFU group as when compared with the MMC only group (generalized Wilcoxon test: p<0.05). No significant side effects due to the combined administration of HCFU were recognized. The combined administration of MMC and HCFU were recognized. The combined administration of MMC and HCFU was suggested to be a safe and effective adjuvant chemotherapy in noncuratively resected cases of colorectal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hoshi A, Iigo M, Nakamura A, Yoshida M, Kuretani K. Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors. Gann 1976; 67: 725–731.

    PubMed  CAS  Google Scholar 

  2. Miura T, Uchiyama T, Takahashi M, Yamamoto K, Koizumi S, Fukamatsu K, Saito J. Physico-chemical properties and stabilities of 1-Hexylcarbamoyl-5-fluorouracil (HCFU). Iyakuhin Kenkyu 1980; 11: 73–81. (in Japanese)

    CAS  Google Scholar 

  3. Fujita H. Fluoropyrimidines (No 3) Carmofur. Pharma Medica 1985; 3: 112–123.

    Google Scholar 

  4. Koyama Y, Hattori T, Inokuchi K. (Cooperative Study Group of HCFU) 1-hexylcarbamoyl-5-fluorouracil (HCFU)-a masked 5-fluorinated pyrimidine. Cancer Treatment Reviews 1981; 8:147–156.

    PubMed  CAS  Google Scholar 

  5. Japanese Research Society for cancer of Colon and Rectum: General rules for clinical and pathological studies on cancer of colon, rectum and anus. Jpn J Surg 1983; 13: 557–573.

    Article  Google Scholar 

  6. Holden WD, Dixon WJ, Kuzma JW. The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of colorectal carcinoma. Ann Surg 1967; 165: 481–503.

    PubMed  CAS  Google Scholar 

  7. Dixon WJ, Longmire WP, Holden WD. Use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of gastric and colorectal carcinomas. Ann Surg 1971; 173: 26–39.

    PubMed  CAS  Google Scholar 

  8. Higgins GA, Dwioht RW, Smoth JV. Fluorouracil as an adjuvant to surgery in carcinoma of the colon. Arch Surg 1971; 102: 339–343.

    PubMed  CAS  Google Scholar 

  9. Imanaga H, Kato K. Adjuvant chemotherapy for colorectal cancer. In: Jinnai D, Murakami T, eds. Choushujutsu no Subete. Tokyo: Kanehara & Co. Ltd. 1978; 2: 657–666. (in Japanese)

    Google Scholar 

  10. Hattori T, Mori S, Hirata K, Ito I. Five year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin C, and/or allogenic bone marrow transplantation. Gan no Rinsho 1973; 19: 241–248. (in Japanese)

    Google Scholar 

  11. Tsuruo T, Iida M, Nakamura K, Tsukagoshi S, Sakurai Y. Inhibition of murine colon adenocarcinomas and Lewis Lung carcinoma by 1-hexylcarbamoyl-5-fluorouracil. Cancer Chemother Pharmacol 1980; 4: 83–87.

    Article  PubMed  CAS  Google Scholar 

  12. Koyama Y, Koyama Y. Phase I study of a new antitumor drug 1-hexycarbamoyl-5-fluorouracil (HCFU), administered orally: An HCFU clinical study group report. Cancer Treat Rep 1980; 64: 861–867.

    PubMed  CAS  Google Scholar 

  13. Koyama Y, Inokuchi K, Koyama Y. (HCFU Clinical Study Group) Absorption and excretion of a new oral antitumor drug, 1-hexylcarbamoyl-5-fluorouracil (HCFU), in cancer patients. Jap J Clin Oncol 1980; 10: 83–92.

    Google Scholar 

  14. Fujita H, Ogawa K.In vivo distribution and activation of 1-hexylcarbamoyl-5-fluorouracil (HCFU). Rinsho Yakuri 1981; 12: 73–83. (in Japanese)

    CAS  Google Scholar 

  15. Shiraishi K, Kubo Y, Majima Y, Sato K, Sakami Y, Sakai T, Hirai K, Ninomiya F, Abe M, Tanikawa K. Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma. Gan to Kagakuryoho 1984; 11: 2348–2355. (English Abst.)

    CAS  Google Scholar 

  16. Watanabe A, Higashi T, Kobayashi M, Nakatsukasa H, Fujiwara M, Shioda T, Yamauchi Y, Ito T, Yamamoto H, Nagashima H. Role of oral administration of 1-hexylcarbomyl-5-fluorouracil (HCFU) for multimodel treatment of inoperable cirrhotics with hepatocellular carcinoma. Gan to Kagakuryoho 1984; 11: 2506–2512. (English Abst.)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Research Institute for Nuclear Medicine and Biology, Hiroshima University, Kasumi 1-2-3, Minami-ku, 734, Hiroshima, Japan

    Minoru Niimoto MD & Takao Hattori

  2. Second Department of Surgery, Kyushu University, Kyushu, Japan

    Ryuichiro Tamada & Keizo Sugimachi

  3. Department of Surgery, Saga Prefectural Kohseikan Hospital, Kohseikan, Japan

    Kiyoshi Inokuchi

  4. Department of Pharmacology, Ehime University, Ehime, Japan

    Nobuya Ogawa

Authors
  1. Minoru Niimoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takao Hattori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryuichiro Tamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keizo Sugimachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kiyoshi Inokuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nobuya Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Niimoto, M., Hattori, T., Tamada, R. et al. Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report). The Japanese Journal of Surgery 17, 354–361 (1987). https://doi.org/10.1007/BF02470634

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02470634

Key Words

Search

Navigation